Knapp J S, Falkow S, Holmes K K
J Clin Pathol. 1975 Apr;28(4):274-8. doi: 10.1136/jcp.28.4.274.
Bacteriocin typing has been described previously and proposed for typing gonococci. A survey has been made of 150 strains of N. gonorrhoeae from various places to determine the feasibility of a gonocin typing system. All strains were found to produce an inhibitory substance which inhibited all strains of gonococci tested, one strain of Neisseria flavescens, two strains of Neisseria meningitidis, as well as the producing strain itself. The inhibitory activity was enhanced by supplementary glucose, reduced by supplementary serum, and unaffected by the addition of HEPES buffer, by the temperature of incubation, or by the exposure of potential producer strains to sublethal concentrations of mitomycin C. This nonspecific inhibitory activity differed from that of a putative bacteriocin produced by a strain of N. meningitidis, in that the latter inhibited most other meningococci but not the producer strain itself. Bacteriocinogeny has not yet been convincingly demonstrated in N. gonorrhoeae, and gonocin typing has not yet been shown to be feasible. Production of the nonspecific inhibitor may have obscured past attempts to demonstrate type-specific gonococcal bacteriocin.
细菌素分型此前已有描述,并被提议用于淋病奈瑟菌的分型。对来自不同地方的150株淋病奈瑟菌进行了一项调查,以确定淋病奈瑟菌分型系统的可行性。发现所有菌株均产生一种抑制物质,该物质能抑制所有受试的淋病奈瑟菌菌株、一株微黄奈瑟菌、两株脑膜炎奈瑟菌以及产生该物质的菌株自身。补充葡萄糖可增强抑制活性,补充血清则使其降低,添加HEPES缓冲液、培养温度或使潜在产生菌暴露于亚致死浓度的丝裂霉素C均不影响该抑制活性。这种非特异性抑制活性不同于一株脑膜炎奈瑟菌产生的一种假定细菌素的抑制活性,后者能抑制大多数其他脑膜炎奈瑟菌,但不抑制产生菌自身。尚未在淋病奈瑟菌中令人信服地证明其产细菌素能力,且淋病奈瑟菌分型也尚未被证明是可行的。这种非特异性抑制剂的产生可能掩盖了过去证明淋病奈瑟菌型特异性细菌素的尝试。